new fda regulations for semaglutide approves first-ever oral GLP-1RA obesity and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults Novo Nordisk calls out dangers

10.1016/j.biopha.2019.109138 83 MacDonaldP

When comparing popular GLP-1 medications, you may notice that they differ in mechanism, dosing schedule, delivery route, and tolerability

Wegovy, the injectable version of semaglutide, is FDA-approved specifically for weight loss in people without diabetes

Lindsley understands the balance between enjoying life and optimizing health

Of course, its early and Phase 3 trials will tell us more, but the numbers so far are unprecedented in obesity pharmacotherapy

As long as you stay within 100 micrograms or less, people are going to lean out a little bit, sleep a little bit better